Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519150 · ClinicalTrials.gov registry record
Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 85
- Enrollment target
NCT05519150: Completed study, sponsored by Indiana University.
NCT05519150 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05519150 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
We believe that kidney donors with kidney stones accepted for a donation do not have an increased risk of loss of kidney function and will not be at increased risk of symptomatic kidney stone events compared to donors without a history of kidney stones.
Primary Outcome
To assess the changes in eGFR and urine protein to urine creatinine ratio in kidney donors with history of kidney stones who donated a kidney 2 or more years ago. We will compare these kidney donors with the age, sex, years since donation and body mass index matched standard (non-stone) kidney donors for absolute eGFR and protein/creatinine urine ratio change, using time as a denominator by paired t-test.
Interventions
- PROCEDURE Blood draw
- DIAGNOSTIC_TEST low dose radiation abdomen/pelvis CT scan (stone protocol)
- OTHER 24 hour urine collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2022-09-02 |
| Est. Completion | 2023-10-10 |
What the finished NCT05519150 record still lists
NCT05519150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT05519150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05519150 about?
NCT05519150 is a clinical study titled "Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.". We believe that kidney donors with kidney stones accepted for a donation do not have an increased risk of loss of kidney function and will not be at increased risk of symptomatic kidney stone events compared to donors without a history of kidney stones.
What is the current status of trial NCT05519150?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2022-09-02. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT05519150?
The interventions under investigation include: Blood draw (PROCEDURE), low dose radiation abdomen/pelvis CT scan (stone protocol) (DIAGNOSTIC_TEST), 24 hour urine collection (OTHER).
Who is sponsoring clinical trial NCT05519150?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI